CurcumaSorb provides the patented Meriva® curcumin-phosphatidylcholine complex for enhanced absorption and bioavailability. The proprietary phytosome technology combines curcumin and phosphatidylcholine at a 1:2 ratio promoting resistance to degradation in the digestive tract and efficient absorption across membranes. This produces significantly higher peak plasma concentrations and larger area under concentration-time curves (AUC). In a single-dose pharmacokinetic animal study, plasma curcumin levels were 20-fold greater with Meriva® than standard curcumin. A preliminary human pharmacokinetic study demonstrated that elevations in plasma curcumin from 450 mg Meriva® were similar to values obtained from 4,000 mg of a standard curcumin extract. The efficacy of a low dose was demonstrated in a 3-month clinical trial, in which 200 mg curcuminoids from Meriva® per day maintained healthy C-reactive protein levels and provided significant benefit in joint comfort, mobility and quality of life.
CurcumaSorb delivers highly bioavailable curcumin, providing maximal support for healthy inflammatory balance, as well as musculoskeletal, digestive, liver, brain, cellular and cardiovascular health.
is a trademark of Indena S.p.A.
Phytosome More Bioavailable is a trademark of Indena S.p.A.
Statements about products on this website have not been evaluated by the Food and Drug Administration.
These products are not intended to diagnose, treat, cure or prevent any disease. If you are pregnant or nursing
consult a healthcare provider before use